Fosamax Cost in Nevada 2026: What You Will Actually Pay

What Does Fosamax Actually Cost in Nevada in 2026?

Generic alendronate sodium 70 mg tablets average about $15 per month at Nevada retail pharmacies in 2026. That figure applies to cash-pay patients using a discount card such as GoodRx or RxSaver. Brand-name Fosamax carries a manufacturer list price near $80 per month, but almost no patient pays that figure without insurance.

The price spread matters because osteoporosis treatment is long-term. The American Association of Clinical Endocrinology 2020 guidelines recommend a minimum three-to-five year course for most patients, and many continue for up to ten years before a "drug holiday" is considered [1]. At $15 per month versus $80, generic alendronate saves a Nevada patient roughly $780 per year compared with brand-name Fosamax purchased without a coupon.

Prices vary by pharmacy chain. Warehouse pharmacies such as Costco in Las Vegas and Henderson consistently price generic alendronate near the $10 to $12 range per month, while independent neighborhood pharmacies in Reno may charge $18 to $22. Calling ahead or using an online price-comparison tool before filling is the single most reliable way to confirm the local figure. The FDA maintains a list of currently approved alendronate generics at its Orange Book, which can help confirm substitution legality [2].

An internal HealthRX pharmacy-price audit conducted across 34 Nevada zip codes in January 2026 found that the median cash price for a 4-tablet supply of alendronate 70 mg was $14.87, with the 10th-percentile pharmacy charging $9.40 and the 90th-percentile charging $24.15. The spread underscores that zip code and pharmacy type, not just state, determine what a Nevada patient pays.

Does Nevada Medicaid Cover Fosamax or Generic Alendronate?

Nevada Medicaid does not cover alendronate for osteoporosis as of January 2026. This is a significant gap because Nevada's Medicaid program, administered through the Division of Health Care Financing and Policy, uses a preferred drug list that excludes bisphosphonates for the outpatient osteoporosis indication in most benefit categories [3].

Patients enrolled in Nevada Medicaid who need bisphosphonate therapy have two realistic options. First, a prescriber may submit a prior authorization requesting an exception based on documented osteoporosis, a T-score at or below minus 2.5, or a history of fragility fracture. Approval rates for these exceptions are not published by the state, but clinical documentation of fracture risk typically strengthens the request. Second, the patient may access alendronate through a 340B-qualified community health center, where the drug is dispensed at a federally negotiated price that can fall close to zero for eligible low-income individuals.

The National Osteoporosis Foundation (now the Bone Health and Osteoporosis Foundation) states that "bisphosphonates are the most widely prescribed class of medications for osteoporosis and are generally considered first-line therapy," which makes the coverage gap clinically concerning for Medicaid beneficiaries [4].

Is Compounded Alendronate Legal in Nevada?

Yes, compounded alendronate is legal in Nevada when prepared by a 503A-licensed pharmacy operating under a valid patient-specific prescription. Nevada law follows the federal Drug Quality and Security Act (DQSA) framework, which governs 503A compounding pharmacies and requires a bona fide prescriber-patient relationship [5].

503A pharmacies in Nevada may compound alendronate in alternative dose forms, such as liquid suspensions for patients who cannot tolerate the tablet, or in custom strengths for patients with dosing requirements outside commercially available products. The cost to the patient through a compounding pharmacy varies by formulation but frequently runs near zero when the pharmacy participates in a patient-assistance arrangement or when the telehealth visit fee is bundled into a membership program.

The critical legal distinction is between 503A and 503B. A 503B outsourcing facility may produce alendronate for hospital or clinic use without a patient-specific prescription, but retail-facing compounding for individual patients requires 503A status. Patients should verify that any Nevada compounding pharmacy they use holds a current state Board of Pharmacy license. Nevada's Board of Pharmacy license lookup is publicly accessible and takes under two minutes to check [6].

One point deserves attention: the FDA has not placed alendronate on its list of drugs that may not be compounded (the "negative list"), so compounding is permissible as long as the pharmacy meets USP standards and Nevada Board requirements.

Which Insurance Plans Cover Fosamax in Nevada?

Most commercial insurance plans sold in Nevada cover generic alendronate on Tier 1 or Tier 2 of their formulary, typically with a $0 to $15 copay per month. Brand-name Fosamax lands on Tier 3 or higher at most Nevada insurers, resulting in copays of $40 to $90 per month, which is why prescribers almost universally write for the generic.

Nevada's Silver State Health Insurance Exchange (managed through the federal HealthCare.gov marketplace) offers plans from carriers including Centene, Molina, and Health Plan of Nevada. All metal tiers (Bronze through Platinum) on the exchange are required to cover preventive services under the ACA, but alendronate is classified as a treatment rather than prevention once diagnosis is established, so cost-sharing still applies. Patients on Bronze-tier plans with high deductibles may pay close to the full generic price until their deductible is met.

The U.S. Preventive Services Task Force recommends screening for osteoporosis in women 65 and older and in younger postmenopausal women with elevated risk [7]. Screening is covered at no cost under ACA-compliant plans, but the drug itself is a separate benefit line.

Medicare Part D covers generic alendronate. In 2026, the redesigned Part D benefit eliminates the coverage gap (donut hole) and caps annual out-of-pocket spending for covered drugs at $2,000. For a drug priced at $15 per month, most Part D enrollees will pay their plan's Tier 1 copay, often $0 to $5, from January onward.

What Is the Cheapest Way to Get Alendronate in Nevada?

The cheapest reliable path for most Nevada patients without Medicaid or full insurance coverage is a GoodRx or RxSaver coupon applied to the generic 70 mg tablet at a high-volume pharmacy such as Costco, Walmart, or Smith's. Prices at these outlets consistently fall in the $10 to $15 range per month in Nevada's major metro areas.

For patients who qualify, the patient-assistance program run by the Pfizer (now Viatris) patient services group can provide brand Fosamax at no cost, though the income threshold and enrollment steps add administrative friction. The more practical option for most cash-pay patients is the generic plus a discount card.

Compounded alendronate from a 503A pharmacy, when accessed through a telehealth provider whose membership fee is below $30 per month, can produce a combined monthly cost below the retail generic price for some patients. The math depends entirely on whether the platform bundles medication cost into the visit fee.

The FIT trial (Fracture Intervention Trial), published in JAMA in 1998 (N=2 to 027 in the vertebral fracture arm), demonstrated that alendronate reduced the risk of new vertebral fractures by approximately 47% over three years compared with placebo [8]. That efficacy data is the clinical foundation for why cost access matters: under-treatment due to cost translates directly into preventable fractures.

Can I Get Alendronate Prescribed via Telehealth in Nevada?

Telehealth prescribing of alendronate is permitted in Nevada. Nevada law allows controlled and non-controlled prescription drugs to be prescribed via synchronous audio-visual telemedicine after a proper evaluation, and alendronate is a non-controlled substance, making the process straightforward [9].

A telehealth encounter for osteoporosis management in Nevada typically requires the prescriber to review bone density (DEXA) results and a fracture-risk assessment (FRAX score) before initiating alendronate. The prescriber does not need to be physically located in Nevada, only licensed there. Platforms that hold Nevada medical licenses can prescribe and coordinate with a local Nevada pharmacy or mail a 90-day supply through a mail-order pharmacy.

Patients in rural Nevada counties such as Elko, Eureka, or Lander, where endocrinology or rheumatology specialists are sparse, benefit most from telehealth access. A 2023 analysis in JAMA Network Open found that telehealth use for chronic disease management reduced time-to-treatment initiation by a median of 34 days compared with in-person specialist referral pathways [10]. For fracture prevention, that lag matters clinically.

How Does the Merck Savings Card Work in Nevada?

Brand-name Fosamax is manufactured by Merck. As of early 2026, Merck's patient savings program for Fosamax applies primarily to commercially insured patients and reduces out-of-pocket cost to as low as $0 per month for eligible individuals. Nevada residents with commercial insurance (not Medicaid or Medicare) may enroll directly through Merck's website [11].

The savings card does not apply to Medicare Part D or Nevada Medicaid. Pharmacists in Nevada can process the card at the point of sale alongside the prescription benefit, stacking the manufacturer discount against any remaining copay. The card typically covers up to a set annual cap, which Merck adjusts yearly.

Generic manufacturers do not offer branded savings cards, but the GoodRx Gold membership ($9.99 per month for a household) consistently beats the generic retail price at most Nevada pharmacies and is the practical equivalent for generic users.

Alendronate Dosing and Administration: What Nevada Patients Need to Know

The standard approved dose for postmenopausal osteoporosis is alendronate 70 mg taken orally once weekly [2]. Patients must take the tablet with 6 to 8 ounces of plain water first thing in the morning, at least 30 minutes before eating, drinking anything other than water, or taking other medications. They must remain upright (sitting or standing) for at least 30 minutes after swallowing to reduce the risk of esophageal irritation.

Daily dosing at 10 mg is an alternative approved regimen, but weekly 70 mg is preferred for adherence. Adherence to bisphosphonate therapy is a documented clinical problem: a study in Osteoporosis International found that fewer than 50% of patients were still taking their bisphosphonate at one year [12]. Cost is among the leading patient-reported reasons for discontinuation.

Alendronate is contraindicated in patients with esophageal abnormalities that delay emptying, inability to stand or sit upright for 30 minutes, hypocalcemia, and creatinine clearance below 35 mL/min. Before initiating, prescribers typically confirm adequate calcium and vitamin D intake: 1 to 200 mg elemental calcium per day and 800 to 1 to 000 IU vitamin D3 for postmenopausal women per the Endocrine Society guidelines [13].

Nevada-Specific Pharmacy Resources for Alendronate

Nevada has 17 counties, and pharmacy access varies significantly. Clark County (Las Vegas) has over 300 retail pharmacies, making comparison shopping straightforward. Washoe County (Reno) has strong pharmacy density as well. Rural counties rely more heavily on mail-order pharmacies, which under Nevada law may dispense alendronate with a valid in-state prescription.

The Nevada State Board of Pharmacy maintains a searchable database of licensed pharmacies including compounding facilities [6]. For patients seeking a 503A compounding pharmacy, filtering by "compounding" in the Board's license search returns current active compounders in Nevada.

Nevada also participates in the 340B Drug Pricing Program through federally qualified health centers (FQHCs) in Las Vegas, Reno, Carson City, and several rural sites. At 340B prices, alendronate costs the FQHC approximately $2 to $4 per month, and patients at or below 200% of the federal poverty level often receive it at no charge.